Medical Device Market Reports for Europe - North, South, Central and Baltic State covers political risk, the business environment, and macro-economic and industry prospects set against assumptions for the global economy.

Dallas, TX (PRWEB) February 10, 2014

The Central Europe and Baltic States Medical Device Market Reports provide the latest available data, expert analysis and our independent 5-year forecasts for key Central Europe and Baltic States markets. Each country report covers political risk, the business environment, and macro-economic and industry prospects set against assumptions for the global economy.

Why These Reports Are Important
Despite on-going economic pressures, the medical device and equipment industry is one of the most successful in terms of its operation. Many leading companies continue to dominate key markets through product innovation, acquisition and mergers, and the sector supports thousands of SME’s developing and sharing novel medical technologies.

With this emphasis on globalisation, one could be forgiven for thinking that national markets are becoming less important. However, it is the national marketplace in which companies have to work. Domestic priorities set the agenda that affects a company's operations. It is the prevailing political outlook, economic performance, health economy, social and demographic trends and cultural views that need to be understood and planned for to ensure optimum return on investment.

Forecast the pace and stability of each South East Europe country's economic and industry growth

Identify and evaluate adverse political and economic trends in key markets, to facilitate risk mitigation strategies

Assess critical shortcomings of each South East Europe country's business environment that pose hidden barriers and costs to corporate profitability

Contextualise individual South East Europe country risks against their regional peers using BMI's country-comparative risk ratings system

Target business opportunities in the key-growth industry sectors

Highlights from the Region
Bulgaria
Funding for healthcare in Bulgaria is principally through compulsory health insurance, operated by the National Health Insurance Fund. The role of the NHIF is to provide a basic package of health services for the whole population. The government is divided on whether to allow private companies to operate in the insurance sector. Private spending is currently almost entirely on an out-of-pocket basis.

Romania
Improvements to the health system continue to be supported by World Bank-sponsored projects. The ‘Health Sector Reform Project APL II’, was approved in December 2004 and will run until December 2012. It aims to improve maternity and newborn care, emergency medical care and rural primary healthcare. The total project cost is estimated at US$206.5 million. A further World Bank health project, with an estimated total cost of US$336.8 million, is currently awaiting approval.

Slovenia
The country remains the richest of the central and eastern European states, and in many ways more closely resembles Italy or Austria than its neighbours to the east. Slovenia joined the European Union in 2004 and adopted the euro in 2007. The economy has suffered a downturn due to the economic recession, albeit less severe than in many of its neighbours. According to Business Monitor International (BMI), GDP is expected to contract by 1.0% in 2012.